Cimzia®

Cimzia® (certolizumab pegol) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells helping to protect healthy cells from damage. Specifically it is a tumor necrosis factor blocker (TNF) for treatment of Crohn’s Disease Rheumatoid Arthritis (RA) Psoriatic Arthritis Ankylosing Spondylitis Non-radiographic Axial Spondylarthritis.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

Cimzia® Referral Form

MANUFACTURER:

UCB Group

CLASS:
TNF alfa inhibitors
WHAT IT TREATS:
PRESCRIBED BY:

Rheumatologists
Gastroenterologists
Dermatologists

HOW ADMINISTERED:
Injection
FREQUENCY:

Administered as an initial dose, then two weeks later, four weeks, and every four weeks after.

Length of infusion:
N/A